Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam.
暂无分享,去创建一个
[1] F. Cobelens,et al. Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam , 2015, BMC Public Health.
[2] A. Dean,et al. The fourth national anti-tuberculosis drug resistance survey in Viet Nam. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[3] W. Yew,et al. Western Pacific Regional Green Light Committee: progress and way forward , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[4] Z. Mor,et al. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[5] A. Van Deun,et al. Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[6] N. Hoa,et al. Prescription patterns and treatment outcomes of MDR‐TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam , 2014, Tropical medicine & international health : TM & IH.
[7] A. Harries,et al. Screening retreatment tuberculosis patients for drug resistance in mid-west Nepal: how well are we doing? , 2014, Public health action.
[8] M. D. Granado,et al. Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[9] S Satyanarayana,et al. Why ethics is indispensable for good-quality operational research. , 2012, Public health action.
[10] A. Harries,et al. Operational Challenges in Diagnosing Multi-Drug Resistant TB and Initiating Treatment in Andhra Pradesh, India , 2011, PloS one.
[11] A. Van Deun,et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. , 2010, American journal of respiratory and critical care medicine.
[12] N. Gandhi,et al. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] F. Cobelens,et al. National survey of tuberculosis prevalence in Viet Nam. , 2010, Bulletin of the World Health Organization.
[14] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[15] A. Ramsay,et al. Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[16] J. Bayona,et al. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[17] J. Andrews,et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. , 2010, American journal of respiratory and critical care medicine.